Anbio Biotechnology (NNNN) Cash & Current Investments (2023 - 2025)

Anbio Biotechnology (NNNN) has 3 years of Cash & Current Investments data on file, last reported at $11.9 million in Q4 2025.

• On a quarterly basis, Cash & Current Investments rose 1.19% year-over-year to $11.9 million in Q4 2025; TTM through Dec 2025 was $11.9 million, a 1.19% increase from a year earlier, with the FY2025 full-year figure at $11.9 million, up 1.19% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $11.9 million, down from $13429.0 billion in the prior quarter.
• Over the last five years, Cash & Current Investments for NNNN reached as high as $13429.0 billion in Q2 2025 and fell as low as $9.7 million in Q4 2023.
• Historically, Cash & Current Investments has averaged $3357.3 billion across 3 years, with a median of $11.8 million in 2024.
• Across the five-year window, Cash & Current Investments increased 21.36% in 2024 and rose 1.19% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $9.7 million in 2023, then advanced by 21.36% to $11.8 million in 2024, then grew by 1.19% to $11.9 million in 2025.
• Per Business Quant data, the three most recent Cash & Current Investments figures were $11.9 million in Q4 2025, $13429.0 billion in Q2 2025, and $11.8 million in Q4 2024.